Упрощенная HTML-версия
74
127.
Hospital-acquired pneumonia guideline committee of the American Thoracic Society &
Infectious Diseases Society of America. Guidelines for the management of adults with
hospital-acquired pneumonia, ventilator- associated pneumonia? And healthcare-
associated pneumonia // Am. J. Respir. Crit. Care Med. – 2005. – Vol. 171. – P. 388-416.
128.
Hsieh C.-H. The role of MIP-1α in the development of systemic inflammatory response
and organ injury following trauma hemorrhage / C.-H. Hsieh, M. Frink, Y.-C. Hsieh [et
al.] // The Journal of Immunology. – 2008. – Vol. 181. – P. 2806-2812.
129.
Ibrahim E.H. A comparative analysis of patients with early-onset vs late-onset
nosocomial pneumonia in the ICU setting / E.H. Ibrahim, S. Ward, G. Sherman // Chest.
– 2000. – Vol. 117. – Р. 1434-1442.
130.
Iregui M. Clinical importance of delays in the initiation of appropriate antibiotic
therapy / M. Iregui, S. Ward, G. Sherman [et al.] // Chest. – 2002. – Vol. 122. – P. 262-
268.
131.
Jones M.R. Lung NF-kappaB activation and neutrophil recruitment require IL-1 and
TNF receptor signaling during pneumococcal pneumonia / M.R. Jones, B.T. Simms,
M.M. Lupa [et al.] // J. Immunol. – 2005. – Vol. 175. – P. 7530-7535.
132.
Jones M.R. Roles of interleukin-6 in activation of STAT proteins and recruitment of
neutrophils during Escherichia coli pneumonia / M.R. Jones, L.J. Quinton, L.J. Simms
[et al.] // J. Infect. Dis. – 2006. – Vol. 193. – P. 360-369.
133.
Joos L. Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of
decline in lung function in smokers / L. Joos, L. McIntyra, J. Ruan [et al.] // Thorax. –
2001. – Vol. 56. – P. 863-866.
134.
Karhukorpi J. Effect of CD14 promoter polymorphism and H. pylori infection and its
clinical outcomes on circulating CD14 / J. Karhukorpi, Y. Yan, S. Nimela [et al.] //
Clin. Exp. Immunol. – 2002. – Vol. 128. – P. 326-332.
135.
Kita M. Role of IFN-gamma in nonviral infection / M. Kita // Nippon. Rinsho. – 2006.
– Vol. 64 (7). – P. 1269-1274.
136.
Kitchens R.L. Plasma CD14 decreases monocyte responses to LPS by transferring cell-
bound LPS to plasma lipoproteins / R.L. Kitchens, P.A. Thompson, S. Viriyakosol [et
al.] // J. Clin. Invest. – 2001. – Vol. 108. – P. 485-493.
137.
Klevents R.M. The impact of antimicrobial-resistant, health care-associated infections
on mortality in the united states / R.M. Klevents, J.R. Edwards, R.P. Gaynes // Clinical
Infectious Diseases. – 2008. – Vol. 47 (1). – P. 927-930.
138.
Koenig W. CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin
receptor CD14, their association with chronic infection and risk of stable coronary artery